Senti Biosciences Holdings (SNTI) Other Working Capital Changes (2021 - 2025)
Senti Biosciences Holdings (SNTI) posted quarterly Other Working Capital Changes of -$4.6 million for Q4 2025, down 232450.0% year-over-year from N/an in Q4 2024, and down 308.67% quarter-over-quarter from $2.2 million in Q3 2025.
Senti Biosciences Holdings (SNTI) Other Working Capital Changes (2021 - 2025) Analysis & Trends
Senti Biosciences Holdings' Other Working Capital Changes history runs 5 years deep, the most recent figure standing at -$4.6 million for Q4 2025.
- In Q4 2025, Other Working Capital Changes fell 232450.0% year-over-year to -$4.6 million; the TTM figure through Dec 2025 stood at -$4.6 million (down 4140.87% YoY), while the FY2025 annual figure was -$4.6 million, down 4140.87% from the prior year.
- Other Working Capital Changes for Q4 2025 stood at -$4.6 million, down from $2.2 million in the prior quarter.
- The five-year high for Other Working Capital Changes was $10.9 million in Q4 2024, with the low at -$10.1 million in Q3 2024.
- The 5-year median for Other Working Capital Changes is $262500.0 (2025), against an average of $14062.5.
- The sharpest annual moves came in 2023 and 2025: Other Working Capital Changes soared 2946.15% in 2023, then sank 232450.0% in 2025.
- Senti Biosciences Holdings' Other Working Capital Changes stood at -$163000.0 in 2021, then jumped by 92.02% to -$13000.0 in 2022, then jumped by 2946.15% to $370000.0 in 2023, then sank by 99.46% to $2000.0 in 2024, then tumbled by 232450.0% to -$4.6 million in 2025.
- Business Quant data shows SNTI's Other Working Capital Changes at -$4.6 million in Q4 2025, $2.2 million in Q3 2025, and -$1.1 million in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn |
| 10 | Senti Biosciences Holdings | 13.66 Mn | 13.66 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 260,000.00 |
| Dec 31, 2025 | 260,000.00 |
| Dec 31, 2025 | 260,000.00 |
| Sep 30, 2025 | 939,000.00 |
| Sep 30, 2025 | 939,000.00 |
| Sep 30, 2025 | 939,000.00 |
| Jun 30, 2025 | -1.42 Mn |
| Jun 30, 2025 | -1.42 Mn |
| Jun 30, 2025 | -1.42 Mn |
| Mar 31, 2025 | 265,000.00 |
| Mar 31, 2025 | 265,000.00 |
| Mar 31, 2025 | 265,000.00 |
| Dec 31, 2024 | 10.92 Mn |
| Dec 31, 2024 | 10.92 Mn |
| Dec 31, 2024 | 10.92 Mn |
| Sep 30, 2024 | -10.15 Mn |
| Sep 30, 2024 | -10.15 Mn |
| Sep 30, 2024 | -10.15 Mn |
| Jun 30, 2024 | -577,000.00 |
| Jun 30, 2024 | -577,000.00 |